Christopher G. Hayes serves as Executive at Verrica Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Christopher G. Hayes has executed 13 insider transactions totaling $570.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 27, 2024 involved selling 9,530 shares valued at $23.4K.
Christopher G. Hayes currently holds 105,773 shares of Verrica Pharmaceuticals Inc. (VRCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher G. Hayes has been a net seller of VRCA stock. They have purchased $62.0K and sold $509.0K worth of shares.
Christopher G. Hayes's most recent insider trade was on Aug 27, 2024, when they sold 9,530 shares at $2.46 per share.
Get notified when new Form 4 filings are submitted
| $2.66 |
| Discretionary |
| Jul 23, 2024 | VRCA | $635 | Sale | 91 | $6.98 | Discretionary |
| Jul 22, 2024 | VRCA | $152.8K | Sale | 21,649 | $7.06 | Discretionary |
| Mar 15, 2024 | VRCA | $0 | Award | 40,000 | $N/A | Discretionary |
| Nov 15, 2023 | VRCA | $34.3K | Sale | 11,558 | $2.97 | Discretionary |
| Nov 14, 2023 | VRCA | $64.9K | Sale | 22,141 | $2.93 | Discretionary |
| Aug 24, 2023 | VRCA | $0 | Award | 75,000 | $N/A | Discretionary |
| Jul 24, 2023 | VRCA | $163.2K | Sale | 33,789 | $4.83 | Discretionary |
| Jul 21, 2023 | VRCA | $0 | Award | 100,000 | $N/A | Discretionary |
| Jul 11, 2022 | VRCA | $25.5K | Purchase | 7,500 | $3.40 | Discretionary |
| Jul 5, 2022 | VRCA | $12.0K | Purchase | 5,714 | $2.10 | Discretionary |
| Jun 4, 2021 | VRCA | $24.5K | Purchase | 2,500 | $9.79 | Discretionary |